Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 71-80 of 312 for

Edit search filters
  1. Utility Of Gallium-68-DOTA-Octreotat PET/CT In The Characterization Of Pediatric Neuroendocrine Tumors

    Rochester, MN

  2. A Study Using Clofarabine and Cytarabine in Treating Children with Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

  3. Effect of Vitamin D Supplementation on Endothelial Function in Obese Adolescents

    Rochester, MN

  4. Fresh Versus Frozen Stool for Fecal Transplant in Children

    Rochester, MN

  5. Bezlotoxumab (MK-6072) Versus Placebo In Children With Clostridium Difficile Infection (CDI) (MK-6072-001)

    Rochester, MN

  6. Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

    Rochester, MN

  7. Pediatric MSC-AFP Sub-study For Crohn's Fistula

    Rochester, MN

  8. Study Evaluating The Safety And Efficacy Of Fenfluramine Hydrochloride Oral Solution As Adjunctive Therapy In Children With Doose Syndrome

    Rochester, MN

  9. A Study Assess The Long-Term Safety Of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution In Children And Young Adults With Dravet Syndrome

    Rochester, MN

  10. Efficacy, Safety, Tolerability, And Pharmacokinetics Of NBI-827104 In Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

    Rochester, MN

.

Mayo Clinic Footer